Clinical Trial Update: Mineralocorticoid Receptor (MR) Antagonist (Eplerenone) vs Amlodipine and STRIATIN [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing the mineralocorticoid receptor antagonist eplerenone against amlodipine and STRIATIN in hypertension has completed with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Amlodipine (amlodipine)
• STRIATIN
• eplerenone (eplerenone)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Hypertension, Genetics Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2025-03-19